Challenge Company D, a privately-held clinical stage biotechnology company engaged in a merger agreement with a publicly traded clinical stage pharmaceutical company and engaged CFGI to assist with audit preparation, accounting and reporting obligations in connection with the merger.
Challenge Company B, a $100MM foreign medical diagnostic company initiated IPO on domestic Form S-1, converting accounting basis from UK GAAP to US GAAP and reporting currency from Pounds Sterling to the US Dollar.
Challenge Company A, a biotech with a Phase II clinical trial asset, engaged CFGI to provide assistance with audit preparation and preparation of Form S-1 in connection with their initial public offering.
Challenge Company C, a US-based clinical research organization, completed an acquisition of a significant business based in Europe.
If you run a business, you lease equipment or real estate.
Whitepaper: Private Equity – Current and emerging financial due diligence considerations when acquiring physician practices
As PE acquisitions of healthcare businesses have surged over the past decade, investments in physician practices and physician practice management (PPM) companies have accelerated apace.
The new accounting standard for revenue recognition (ASC 606), which goes into effect early next year for privately held companies is just an accounting change, right? Not at all.
While there is no magic formula for transitioning a company from “fact finding” to the “CECL sanctioned” state, we have outlined an adoption roadmap that can be tailored for the idiosyncrasies inherent in every business.